Mental and behavioural disorders due to opioids

F5_OPIOIDS

opioid dependence: Disorders related or resulting from abuse or mis-use of opioids.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — F11 Hospital discharge: ICD-9 — 3040\|3055 Hospital discharge: ICD-8 — 304[0-1] Cause of death: ICD-10 — F11 Cause of death: ICD-9 — 3040\|3055 Cause of death: ICD-8 — 304[0-1] 2 out of 7 registries used, show all original rules.	1539
4. Check minimum number of events None	1539
5. Include endpoints None	1539
6. Filter based on genotype QC (FinnGen only)	1539

Control definitions (FinnGen only)

Control exclude: F5_SUBSNOALCO

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: F10-F19
Name in latin: Perturbationes mentis et modi se gerendi ex usu opioidum

NAME	F5_OPIOIDS
CONTROL_EXCLUDE	F5_SUBSNOALCO
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	F11
HD_ICD_9	3040\|3055
HD_ICD_8	304[0-1]
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	F11
COD_ICD_9	3040\|3055
COD_ICD_8	304[0-1]
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Mental and behavioural disorders due to opioids based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	18149	6045	11977
Only index persons	16497	5574	10923
Unadjusted period prevalence (%)
Whole population	0.28	0.17	0.33
Only index persons	0.35	0.20	0.42
Median age at first event (years)
Whole population	29.82	29.12	30.11
Only index persons	29.40	28.45	29.89

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	1539	681	858
Unadjusted period prevalence (%)	0.31	0.23	0.38
Median age at first event (years)	31.77	31.26	32.17

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
1397: Matched controls
13970

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

N05BA04

ATC

oxazepam; oral

11.1

323.0

865

1787

F11.29

ICD-10 Finland

Addiction caused by opiates UNS

2260.2

323.0

334

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

37.2

323.0

487

198

F15.2

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome

3632.8

323.0

301

N05AH03

ATC

olanzapine; systemic

20.3

323.0

545

427

N05AH04

ATC

quetiapine; oral

21.1

323.0

983

1415

F11.22

ICD-10 Finland

Addiction-induced dependence is currently independent but uses substitute intermittent medication

3017.5

323.0

649

Z72.2

ICD-10 Finland

Drug use

283.5

323.0

343

N03AE01

ATC

clonazepam; systemic

30.9

323.0

501

248

B18.2

ICD-10 Finland

Chronic viral hepatitis C

396.5

323.0

655

F11.24

ICD-10 Finland

Addiction-induced dependence caused by opiates active addiction

5499.7

323.0

409

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

2540.1

323.0

360

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

4468.1

323.0

352

N05BA01

ATC

diazepam; systemic, rectal

24.5

323.0

777

680

F11.25

ICD-10 Finland

Relationship caused by opiates continuously used

+∞

323.0

486

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

21.0

323.0

652

557

T36

ICD-10 Finland

Poisoning by systemic antibiotics

39.0

323.0

585

253

P19

ICPC

Drug abuse

241.1

323.0

498

F11.20

ICD-10 Finland

Addiction-induced dependence caused by opiates currently independent

+∞

319.4

294

N06AX11

ATC

mirtazapine; oral

8.9

301.6

923

2504

N05CD07

ATC

temazepam; oral

19.2

291.8

472

361

N05BA12

ATC

alprazolam; oral

14.4

289.3

539

582

F19.20

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent

3057.7

281.9

263

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

16.1

266.7

465

420

F11.1

ICD-10 Finland

Mental and behavioural disorders due to use of opioids, harmful use

+∞

251.9

234

F13.25

ICD-10 Finland

Addiction caused by sedative and hypnotic continuous use

952.5

250.1

238

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

705.6

246.1

236

N05AA02

ATC

levomepromazine; systemic

27.4

245.0

345

165

SPAT1275

SPAT

Drug rehabilitation and replacement therapy of opioid-dependent person

125.2

241.8

256

F19.24

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction

+∞

240.8

224

F29

ICD-10 Finland

Unspecified nonorganic psychosis

18.3

239.3

390

289

N06AX16

ATC

venlafaxine; oral

8.8

235.5

597

1087

F32.9

ICD-10 Finland

Depressive episode, unspecified

8.8

234.2

598

1100

F19.25

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances continuously used

+∞

227.5

212

F15.1

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, harmful use

2342.1

225.2

212

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

12.0

222.4

447

528

N03AX16

ATC

pregabalin; oral

7.6

221.6

639

1392

N06AB04

ATC

citalopram; systemic

7.3

214.0

640

1454

F19.21

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances currently independent but staying in a controlling environment

+∞

206.5

193

C07AA05

ATC

propranolol; systemic

6.9

205.1

636

1500

P18

ICPC

Medication abuse

201.0

202.0

206

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

8.6

200.4

498

841

N03AX12

ATC

gabapentin; oral

8.3

189.3

479

822

F13.29

ICD-10 Finland

Addiction caused by sedative and hypnotic UNS

525.6

189.0

184

F11.21

ICD-10 Finland

Addiction-indiced dependence caused by opiates currently independent but staying in controlling environment

+∞

186.7

175

F11.30

ICD-10 Finland

Withdrawal symptoms caused by opiates uncomplicated

+∞

186.7

175

N05AX08

ATC

risperidone; systemic

11.2

185.4

381

453

N05CF01

ATC

zopiclone; oral

5.7

176.4

672

1967

F13.20

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent

1970.7

175.8

167

N03AG01

ATC

valproic acid; systemic, rectal

12.2

172.6

336

354

N07BB01

ATC

disulfiram; oral

12.9

170.7

322

317

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

11.0

168.3

346

405

R56.8

ICD-10 Finland

Other and unspecified convulsions

13.4

166.1

307

288

F13.24

ICD-10 Finland

Addiction relationship caused by sedative and hypnotic active addiction

598.7

164.6

160

F12.1

ICD-10 Finland

Mental and behavioural disorders due to use of cannabinoids, harmful use

598.7

164.6

160

A46

ICD-10 Finland

Erysipelas

8.6

164.0

397

617

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

24.4

155.4

225

109

Z2446

NOMESCO Finland

Social worker

10.6

154.8

323

384

N06AB06

ATC

sertraline; oral

6.9

151.5

434

855

N02AX02

ATC

tramadol; systemic, rectal

4.6

149.9

769

2944

SPAT1272

SPAT

Drug screening

85.2

149.3

166

AA1AD

NOMESCO Finland

CT of head and brain

6.0

148.4

490

1158

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

16.1

148.4

250

186

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

6.6

146.6

436

899

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

15.1

143.0

248

197

N05AX12

ATC

aripiprazole; systemic

11.2

142.5

287

315

N06AB10

ATC

escitalopram; oral

4.8

142.5

620

1983

F15.5

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, psychotic disorder

+∞

142.1

134

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

34.8

141.3

185

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

7.5

139.7

369

639

N05AF03

ATC

chlorprothixene; systemic

20.6

138.7

212

120

SPAT1265

SPAT

Breathalyser

37.6

138.5

178

N05CF02

ATC

zolpidem; oral

5.5

137.5

492

1261

F19.30

ICD-10 Finland

Withdrawal symptoms caused by several drugs in combination and by other psychoactive substances uncomplicated

+∞

135.7

128

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

20.1

134.2

207

120

F19.9

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, unspecified mental and behavioural disorder

+∞

132.4

125

F11.9

ICD-10 Finland

Mental and behavioural disorders due to use of opioids, unspecified mental and behavioural disorder

+∞

131.3

124

F13.1

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use

461.9

129.1

127

N05BE01

ATC

buspirone; oral

19.4

128.8

201

120

SPAT1254

SPAT

Administration of medicine

6.1

123.6

384

815

N06AB03

ATC

fluoxetine; oral

6.2

122.7

374

774

N06AX21

ATC

duloxetine; oral

6.8

120.4

338

625

J18.9

ICD-10 Finland

Pneumonia, unspecified

5.1

118.5

447

1184

F10.20

ICD-10 Finland

Alcohol dependence currently independent

22.9

118.4

174

F19.2

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, dependence syndrome

+∞

115.2

109

N05AD01

ATC

haloperidol; systemic

19.4

114.5

178

104

F60.2

ICD-10 Finland

Dissocial personality disorder

212.5

114.4

117

N06AA12

ATC

doxepin; systemic

13.5

113.7

206

177

SPAT1227

SPAT

Substance abuse rehabilitation

53.2

112.9

135

F10.25

ICD-10 Finland

Alcohol dependence continuous use

25.9

111.0

157

EBA00

NOMESCO Finland

Extraction of tooth

3.6

110.0

739

3286

F13.3

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, withdrawal state

570.4

108.3

106

F11.2

ICD-10 Finland

Mental and behavioural disorders due to use of opioids, dependence syndrome

+∞

107.7

102

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

49.3

107.2

130

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

22.4

106.8

158

GD1AA

NOMESCO Finland

Thorax X-ray examination

3.7

106.7

664

2753

N03AX09

ATC

lamotrigine; oral

8.4

105.6

249

350

JJ1LE

NOMESCO Finland

Ultrasound elastography of liver

48.5

105.2

128

K04.5

ICD-10 Finland

Chronic apical periodontitis

4.1

104.8

522

1783

N05BA02

ATC

chlordiazepoxide; systemic

25.0

103.6

148

ZY010

NOMESCO Finland

Hospital outpatient

8.4

102.8

243

342

Z3231

NOMESCO Finland

Registered nurse

3.9

102.1

534

1895

A49.9

ICD-10 Finland

Bacterial infection, unspecified

7.7

101.4

254

391

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

6.5

101.0

290

542

ZY000

NOMESCO Finland

Hospital inpatient

27.2

100.5

140

P15

ICPC

Chronic alcohol abuse

12.1

99.7

190

180

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

12.1

99.7

190

180

N06AB05

ATC

paroxetine; oral

7.6

99.3

251

391

F60.9

ICD-10 Finland

Personality disorder, unspecified

20.9

99.2

150

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

6.7

98.0

273

488

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

5.2

97.0

343

822

N02AA05

ATC

oxycodone; systemic

6.7

96.6

269

480

X59

ICD-10 Finland

Exposure to unspecified factor

4.0

96.1

470

1556

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

8.8

95.8

219

290

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

13.6

95.3

171

142

P29

ICPC

Psychological sympt/compl other

6.5

93.7

267

490

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

11.6

92.3

179

175

EBA30

NOMESCO Finland

Excision of root of tooth

10.6

91.9

187

201

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

3.2

90.9

899

5052

T74.1

ICD-10 Finland

Physical abuse

11.2

90.7

179

181

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

15.3

90.1

153

111

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

4.8

90.0

348

911

N06AX12

ATC

bupropion; oral

5.6

88.9

289

623

F10.24

ICD-10 Finland

Alcohol depence active use

20.7

88.6

134

F19.00

ICD-10 Finland

Intoxication caused by several drugs in combination or by other psychoactive substances uncomplicated

+∞

88.5

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

14.6

87.1

151

115

Z86.4

ICD-10 Finland

Personal history of psychoactive substance abuse

70.9

86.8

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

7.9

85.5

208

302

TPH04

NOMESCO Finland

Cathetrisation of vein

4.1

85.3

400

1253

IFC01

NOMESCO Finland

Withdrawal and replacement therapy for opioid addiction

+∞

85.3

XF400

NOMESCO Finland

ECG with 12 standard connections

5.0

84.8

310

760

F10.09

ICD-10 Finland

Alcohol intoxication UNS

14.4

84.4

147

113

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

7.0

84.2

224

371

F20.9

ICD-10 Finland

Schizophrenia, unspecified

14.0

83.5

147

116

F61.0

ICD-10 Finland

Mixed personality disorders

15.1

83.2

142

104

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

17.7

82.4

132

K08.3

ICD-10 Finland

Retained dental root

7.6

82.4

206

311

N05BA06

ATC

lorazepam; systemic, sublingual

10.2

82.2

170

187

A06AD11

ATC

lactulose; oral

5.7

82.1

261

544

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

4.9

80.5

299

741

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

21.6

79.8

119

F19.26

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances periodic addiction

+∞

78.9

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

8.2

78.0

184

253

N05AB03

ATC

perphenazine; systemic, rectal

10.4

77.7

159

171

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

7.4

77.3

197

305

EBA05

NOMESCO Finland

Complicated extraction of tooth

3.5

77.3

440

1604

F11.39

ICD-10 Finland

Withdrawal symptoms caused by opiates without information about seizures

790.1

77.1

WX110

NOMESCO Finland

Local anesthesy

3.4

77.0

1143

8000

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

7.4

77.0

195

299

F13.21

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but staying in a controlling environment

+∞

76.8

F12.29

ICD-10 Finland

Addiction caused by cannabis UNS

+∞

76.8

WX290

NOMESCO Finland

Other blockade of nerve

2.9

76.5

918

5555

N06AA09

ATC

amitriptyline; systemic

6.3

76.5

220

402

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

5.1

76.0

268

625

S06.0

ICD-10 Finland

Concussion

4.6

74.5

292

760

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

9.9

74.1

155

173

EB1AA

NOMESCO Finland

Tooth X-ray examination

2.9

73.7

939

5835

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

9.9

72.9

153

172

B17.1

ICD-10 Finland

Acute hepatitis C

745.6

72.8

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

17.7

72.7

116

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

2.8

71.7

740

4008

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

18.2

71.7

113

J01FF01

ATC

clindamycin; systemic

3.1

71.6

501

2107

P16

ICPC

Acute alcohol abuse

14.0

71.3

125

WX892

NOMESCO Finland

Monitored bed care

6.8

71.3

192

320

ZXD05

NOMESCO Finland

Urgent procedure

3.0

71.3

585

2737

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

8.2

70.6

166

226

K02.1

ICD-10 Finland

Caries of dentine

2.9

70.4

1028

6852

R52.2

ICD-10 Finland

Other chronic pain

10.8

69.6

139

142

F19.09

ICD-10 Finland

Intoxication caused by several drugs in combination and by other psychoactive substances UNS

+∞

69.3

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

5.5

68.6

220

457

N05AH02

ATC

clozapine; systemic

11.2

68.6

134

131

R50.9

ICD-10 Finland

Fever, unspecified

3.9

67.2

319

985

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

5.9

67.0

202

389

S18

ICPC

Laceration/cut

2.8

67.0

600

2939

F19.22

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances currently independent but using substitute intermittent medication

+∞

66.2

P01

ICPC

Feeling anxious/nervous/tense

3.7

65.5

341

1135

-1

NOMESCO Finland

2.7

65.5

668

3525

P74

ICPC

Anxiety disorder/anxiety state

7.0

65.4

172

276

A01

ICPC

Pain general/multiple sites

5.9

65.4

198

383

IGV01

NOMESCO Finland

Psychiatric network contact

30.2

65.4

ZXY51

NOMESCO Finland

2-person team, doctor-nurse

14.4

64.7

112

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.7

64.5

619

3143

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

11.7

64.1

122

113

F19.59

ICD-10 Finland

Psychotic disorder caused by several drugs in combination and by other psychoactive substances UNS

+∞

64.0

A41.9

ICD-10 Finland

Sepsis, unspecified

13.4

63.8

114

SPAT1301

SPAT

No procedures

2.9

63.2

517

2367

F12.25

ICD-10 Finland

Dependence caused by cannabis continuous use

+∞

63.0

SPAT1240

SPAT

Therapeutic discussion

3.6

62.9

334

1124

N06AX05

ATC

trazodone; oral

11.8

62.8

119

109

SAA01

NOMESCO Finland

Simple examination of mouth

3.0

62.7

1144

8391

WZB00

NOMESCO Finland

Telephone receipt or other advice

2.7

62.5

590

2949

T40.9

ICD-10 Finland

Poisoning: Other and unspecified psychodysleptics [hallucinogens]

102.0

62.4

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

11.7

62.0

118

109

C03CA01

ATC

furosemide; systemic

3.9

62.0

293

895

N06AX03

ATC

mianserin; oral

8.8

62.0

138

171

F19.50

ICD-10 Finland

Psychotic disorder caused by several drugs in combination and by other psychoactive substances schizophrenic

+∞

61.9

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

17.4

61.8

N04AA02

ATC

biperiden; systemic

16.4

61.7

101

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

6.4

61.6

172

299

EBA15

NOMESCO Finland

Extraction of large number of teeth

9.5

61.0

130

149

F20.09

ICD-10 Finland

Paranoid schizophrenia UNS

23.4

60.9

F15.0

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, acute intoxication

+∞

60.9

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.9

60.8

473

2088

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

18.0

60.8

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

8.6

60.3

136

172

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

18.6

60.2

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

6.0

60.0

178

334

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

13.2

59.7

107

3049X

ICD-9 Finland

Drug dependence, Unspecified drug dependence

+∞

58.8

339

Kela drug reimbursment

Product containing buprenorfine and naloxone

+∞

58.8

T40.6

ICD-10 Finland

Poisoning: Other and unspecified narcotics

208.7

58.5

M79.6

ICD-10 Finland

Pain in limb

2.7

58.2

543

2665

F15.3

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, withdrawal state

+∞

57.7

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

3.9

57.6

272

825

P99

ICPC

Psychological disorders other

7.7

57.1

139

198

K04.0

ICD-10 Finland

Pulpitis

3.6

56.9

291

943

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

14.4

56.8

SPAT1260

SPAT

Consultation of another employee

3.4

56.5

326

1160

J01DB01

ATC

cefalexin; oral

3.2

56.4

1212

9425

F41.09

ICD-10 Finland

UNS Panic Syndrome

7.4

56.3

140

206

M54.5

ICD-10 Finland

Low back pain

2.6

56.2

566

2890

SPAT1148

SPAT

Treatment of chronic ulcer or burn

4.6

56.0

211

517

TKC20

NOMESCO Finland

Catheterisation of bladder

6.9

55.8

147

235

ZXE10

NOMESCO Finland

More than one and less than three hours

2.7

55.7

524

2569

F12.21

ICD-10 Finland

Dependence caused by cannabis currently independent but staying in a controlling environment

+∞

55.6

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

10.2

55.3

113

120

IFC99

NOMESCO Finland

Other biological psychiatric intervention

123.1

55.2

RS220

NOMESCO Finland

20.5

55.1

R41.0

ICD-10 Finland

Disorientation, unspecified

15.1

54.5

N06AA06

ATC

trimipramine; systemic

11.5

54.4

104

L17

ICPC

Foot/toe symptom/complaint

3.0

53.9

385

1586

N05CD08

ATC

midazolam; nasal, systemic

20.4

53.7

NA1AD

NOMESCO Finland

Cervical spine CT examination

7.5

53.3

131

189

SGA01

NOMESCO Finland

Tooth opening as first aid

2.9

53.3

386

1601

F51.0

ICD-10 Finland

Nonorganic insomnia

3.3

53.2

313

1123

L03.9

ICD-10 Finland

Cellulitis, unspecified

14.2

53.1

N05AA01

ATC

chlorpromazine; systemic, rectal

21.7

52.8

ZXY60

NOMESCO Finland

2-person team, nurses

28.0

52.6

F11.09

ICD-10 Finland

Intoxication caused by opiates UNS

+∞

52.4

O35.5

ICD-10 Finland

Maternal care for (suspected) damage to fetus by drugs

187.0

52.3

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

25.6

52.0

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

9.1

51.9

113

134

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

11.1

51.5

100

N03AF01

ATC

carbamazepine; oral, rectal

7.0

51.2

132

204

IEV99

NOMESCO Finland

Other psychiatric network intervention

33.4

51.2

O98.4

ICD-10 Finland

Viral hepatitis complicating pregnancy, childbirth and the puerperium

515.9

50.7

S10

ICPC

Boil/carbuncle

5.5

50.7

159

317

A02BC02

ATC

pantoprazole; systemic

2.3

50.7

834

5401

F11.26

ICD-10 Finland

Addiction caused by opiates intermittent drug addiction

+∞

50.3

N05AB01

ATC

dixyrazine; systemic

24.9

50.2

N06BA04

ATC

methylphenidate; oral

6.4

49.7

137

232

F13.2

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, dependence syndrome

259.0

49.4

X78

ICD-10 Finland

Intentional self-harm by sharp object

25.8

49.3

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

5.0

49.2

170

378

WX002

NOMESCO Finland

Sedation and analgesia

3.2

49.2

295

1069

S01.0

ICD-10 Finland

Open wound of scalp

4.6

49.1

185

451

Z71.8

ICD-10 Finland

Other specified counselling

2.6

48.7

445

2110

M54.9

ICD-10 Finland

Dorsalgia, unspecified

3.6

48.6

242

759

N05AN01

ATC

lithium; oral

8.3

48.5

111

143

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

5.1

48.2

163

354

F12.24

ICD-10 Finland

Addiction caused by cannabis active addiction

+∞

48.2

T40.2

ICD-10 Finland

Poisoning: Other opioids

+∞

48.2

F11.00

ICD-10 Finland

Intoxication caused by opiates uncomplicated

+∞

48.2

D72

ICPC

Viral hepatitis

107.9

48.1

R1210

NOMESCO Finland

Medical assessment of need and possibilities to rehabilitation

15.0

48.0

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

4.5

48.0

185

461

ZXY49

NOMESCO Finland

Other health care provider

34.1

47.7

SPAT1307

SPAT

Psychosocial counselling and guidance

3.9

47.7

215

620

ICB02

NOMESCO Finland

Psychiatric treatment plan, extended/prolonged

16.1

47.6

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

13.0

47.4

L03

ICPC

Low back symptom/complaint

2.6

47.4

420

1951

Z3226

NOMESCO Finland

Physiotherapist

3.1

47.2

300

1128

N07BC51

ATC

buprenorphine, combinations; sublingual

+∞

47.1

F12.20

ICD-10 Finland

Dependence caused by cannabis currently independent

+∞

47.1

F90.0

ICD-10 Finland

Disturbance of activity and attention

5.2

47.0

155

327

SPAT1247

SPAT

Outpatient detoxication and monitoring

27.9

46.8

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

3.1

46.7

298

1125

Z2221

NOMESCO Finland

Medical doctor

2.6

46.5

451

2199

TPH07

NOMESCO Finland

Cathetrisation of artery

4.6

45.9

171

411

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

18.0

45.9

S76

ICPC

Skin infection other

6.4

45.8

126

213

F41.1

ICD-10 Finland

Generalized anxiety disorder

4.6

45.6

169

404

IER04

NOMESCO Finland

Rehabilitative psychiatric group intervention, functional

22.3

45.2

L12

ICPC

Hand/finger symptom/complaint

3.2

44.7

266

952

J01MA12

ATC

levofloxacin; systemic

3.2

44.7

272

990

ZXD35

NOMESCO Finland

Usual procedure

7.7

44.7

107

148

T65.9

ICD-10 Finland

Toxic effect: Toxic effect of unspecified substance

66.1

44.4

Y04.9

ICD-10 Finland

Assault by bodily force by unknown person

12.8

44.3

K04.1

ICD-10 Finland

Necrosis of pulp

3.4

44.2

240

800

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.7

44.2

364

1608

R02

ICPC

Shortness of breath/dyspnoea

3.8

44.0

206

611

F99

ICD-10 Finland

Mental disorder, not otherwise specified

8.0

43.9

103

138

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

3.0

43.8

301

1189

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

4.1

43.6

187

513

T51.0

ICD-10 Finland

Toxic effect: Ethanol

20.6

43.4

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

2.3

43.3

590

3394

F39

ICD-10 Finland

Unspecified mood [affective] disorder

8.7

43.2

118

F11.23

ICD-10 Finland

Addiction-induced dependence is currently independent but uses aversion-inducing medication

+∞

42.9

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

9.5

42.6

101

N05CD02

ATC

nitrazepam; oral

23.6

42.6

SPAT1263

SPAT

Sampling

2.2

42.4

640

3852

X57

ICD-10 Finland

Unspecified privation

9.9

42.3

-50

ICPC

Medication/prescr/renewal

6.7

42.2

112

180

SPAT1222

SPAT

Counselling/guidance promoting independent living

3.6

42.1

212

667

IAB10

NOMESCO Finland

Psychiatric consultation concerning substance abuse

116.1

42.0

3044A

ICD-9 Finland

Drug dependence, Amphetamine and other psychostimulant dependence

+∞

41.9

Z76.0

ICD-10 Finland

Issue of repeat prescription

2.9

41.7

292

1162

A03FA01

ATC

metoclopramide; systemic, rectal

2.9

41.7

288

1134

N06AX26

ATC

vortioxetine; oral

4.0

41.5

180

498

SGA02

NOMESCO Finland

Opening and dilatation of root canal of tooth

3.1

41.5

262

973

JN3BD

NOMESCO Finland

Extensive abdominal CT

3.9

41.2

183

517

R07.4

ICD-10 Finland

Chest pain, unspecified

2.7

41.2

335

1460

X58

ICD-10 Finland

Exposure to other specified factors

2.8

41.1

311

1300

Z2445

NOMESCO Finland

Psychologist

5.1

40.8

135

285

N05AD03

ATC

melperone; systemic

20.5

40.8

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

2.4

40.6

436

2215

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

5.5

40.6

127

251

N02BE01

ATC

paracetamol; systemic, rectal

2.5

40.6

1147

9091

W19

ICD-10 Finland

Unspecified fall

3.9

40.6

183

524

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

3.8

40.4

186

542

F20.39

ICD-10 Finland

Undifferentiated schizophrenia UNS

20.8

40.3

A03

ICPC

Fever

2.6

40.3

364

1683

SPAT1249

SPAT

Treatment-related counselling outside office

2.2

40.2

597

3539

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

18.5

40.0

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

26.0

39.6

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

22.8

39.4

F05.9

ICD-10 Finland

Delirium, unspecified

16.3

39.4

P72

ICPC

Schizophrenia

8.5

39.4

109

K04.7

ICD-10 Finland

Periapical abscess without sinus

4.6

39.4

145

343

N07BA03

ATC

varenicline; oral

4.4

39.4

151

372

F23.99

ICD-10 Finland

Acute and transient psychosis, unspecified UNS

28.9

39.3

SPAT1310

SPAT

Counselling related to known health issue

2.3

39.2

485

2632

WX730

NOMESCO Finland

Conventional respirator

14.3

39.1

R11

ICD-10 Finland

Nausea and vomiting

4.0

39.1

169

466

A28

ICPC

Limited function/disability NOS

4.3

39.0

154

390

C07AB07

ATC

bisoprolol; oral

2.3

38.9

444

2318

3040A

ICD-9 Finland

Drug dependence, Opioid type dependence

+∞

38.7

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

8.4

38.7

109

R33

ICD-10 Finland

Retention of urine

6.1

38.6

109

190

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

16.0

38.6

SPAT1234

SPAT

Support of social functional capacity

6.0

38.1

110

197

X99.9

ICD-10 Finland

Assault by sharp object by unknown person

73.7

38.1

N06CA01

ATC

amitriptyline and psycholeptics; systemic

4.1

38.1

159

424

OAB43

SPAT

0.2

37.9

2240

F40.1

ICD-10 Finland

Social phobias

5.8

37.9

112

207

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

6.7

37.8

156

IEY01

NOMESCO Finland

Psychoeducation, individual

19.8

37.7

K04.08

ICD-10 Finland

Other specified pulpit

3.5

37.7

195

624

SPAT1215

SPAT

Assessment of need for medical rehabilitation

5.3

37.5

119

239

R52.9

ICD-10 Finland

Pain, unspecified

3.9

37.4

165

462

R53

ICD-10 Finland

Malaise and fatigue

2.6

37.4

324

1456

Z00.0

ICD-10 Finland

General medical examination

2.7

37.4

304

1318

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.8

37.3

272

1105

S29

ICPC

Skin symptom/complaint other

3.0

37.2

248

950

ZXY83

NOMESCO Finland

Social worker in multidisciplinary team

46.4

37.1

N05AF05

ATC

zuclopenthixol; systemic

17.7

36.9

Y07

ICD-10 Finland

Other maltreatment

13.3

36.8

D10

ICPC

Vomiting

3.5

36.8

185

578

F19.53

ICD-10 Finland

Psychotic disorder caused by several drugs in combination and by other psychoactive substances polymorphic

+∞

36.6

S97

ICPC

Chronic ulcer skin

6.7

36.0

151

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

7.8

36.0

115

L02

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle

5.4

36.0

112

220

R06.0

ICD-10 Finland

Dyspnoea

2.6

35.9

298

1305

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

2.2

35.8

485

2718

Z72.1

ICD-10 Finland

Alcohol use

13.7

35.7

IGY02

NOMESCO Finland

Psychiatric monitoring contact

7.1

35.3

133

WX408

NOMESCO Finland

General anesthesy, balanced

2.3

35.1

389

1982

IBZ03

NOMESCO Finland

Addiction psychiatry evaluation

355.8

35.1

Z46.3

ICD-10 Finland

Fitting and adjustment of dental prosthetic device

20.7

35.0

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

2.0

34.8

659

4249

K10.3

ICD-10 Finland

Alveolitis of jaws

4.3

34.7

136

341

ZXE20

NOMESCO Finland

More than three and less than five hours

3.2

34.6

203

710

F92.0

ICD-10 Finland

Depressive conduct disorder

21.1

34.6

ZXE00

NOMESCO Finland

One hour or less

2.1

34.3

554

3342

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

2.2

34.1

486

2775

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

3.0

34.1

215

790

R51.80

ICD-10 Finland

Headache

2.6

34.1

290

1283

A02BC01

ATC

omeprazole; systemic

2.4

34.0

343

1663

KMAK

NOMESCO Finland

2.0

33.9

862

6219

3018D

ICD-9 Finland

Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]

36.9

33.9

ZYC01

NOMESCO Finland

Remote contact by phone

4.7

33.6

120

274

3041A

ICD-9 Finland

Drug dependence, Barbiturate and similarly acting sedative or hypnotic dependence

+∞

33.5

F12.5

ICD-10 Finland

Mental and behavioural disorders due to use of cannabinoids, psychotic disorder

+∞

33.5

WX872

NOMESCO Finland

Intensive care

5.9

33.4

175

SPAT1274

SPAT

Brief intervention in person with addiction symptoms

26.4

33.3

M01AB51

ATC

indometacin, combinations; oral, rectal

10.0

33.1

T40.4

ICD-10 Finland

Poisoning: Other synthetic narcotics

334.6

33.0

R4110

NOMESCO Finland

Physiotherapy

2.4

33.0

351

1742

X84

ICD-10 Finland

Intentional self-harm by unspecified means

36.0

32.9

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

4.5

32.9

122

290

Z22.5

ICD-10 Finland

Carrier of viral hepatitis

174.1

32.8

K59.09

ICD-10 Finland

Constipation, unspecified

5.3

32.8

104

209

L28

ICPC

Limited function/disability (L)

3.4

32.7

174

566

SPAT1149

SPAT

Suture or treatment of traumatic wound

3.2

32.5

187

644

IBZ04

NOMESCO Finland

Replacement therapy evaluation for person with opioid addiction

+∞

32.4

F19.39

ICD-10 Finland

Withdrawal symptoms caused by several drugs in combination and by other psychoactive substances UNS

+∞

32.4

F19.40

ICD-10 Finland

Withdrawal symptoms with delirium caused by several drugs in combination and by other psychoactive substances without seizures

+∞

32.4

ZXY82

NOMESCO Finland

Nurse in multidisciplinary team

23.7

32.4

SGC00

NOMESCO Finland

Local medication of root channels of tooth

2.8

32.2

224

877

JN4BD

NOMESCO Finland

Extensive body CT

3.9

32.1

139

382

SGB10

NOMESCO Finland

Fiiling of rooth of tooth with one root channel

3.0

32.1

201

735

M54.4

ICD-10 Finland

Lumbago with sciatica

2.6

32.0

259

1109

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

5.3

31.9

101

202

P01AB01

ATC

metronidazole; oral, rectal

2.1

31.8

512

3057

F43.1

ICD-10 Finland

Post-traumatic stress disorder

5.8

31.7

170

C02AC01

ATC

clonidine; systemic

48.7

31.7

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

19.1

31.5

Z03

ICPC

Housing/neighbourhood problem

23.2

31.5

IEY08

NOMESCO Finland

Psychiatric coaching, domestic and community skills

32.4

31.4

F13.09

ICD-10 Finland

Intoxication caused by sedative and hypnotic UNS

+∞

31.4

F41.00

ICD-10 Finland

Moderate panic disorder

7.3

31.3

111

F20.0

ICD-10 Finland

Paranoid schizophrenia

14.4

31.3

R74

ICPC

Upper respiratory infection acute

2.0

31.3

545

3355

D11

ICPC

Diarrhoea

2.7

31.3

240

995

Y09

ICD-10 Finland

Assault by unspecified means

15.0

31.1

R60.0

ICD-10 Finland

Localized oedema

3.6

31.0

150

452

SPAT1270

SPAT

Narcotic/sobriety test

43.3

31.0

RS310

NOMESCO Finland

43.3

31.0

V49.9

ICD-10 Finland

Car occupant [any] injured in unspecified traffic accident

4.4

31.0

117

283

Z35.7

ICD-10 Finland

Supervision of high-risk pregnancy due to social problems

30.1

30.8

P06

ICPC

Sleep disturbance

3.0

30.8

196

721

F10.23

ICD-10 Finland

Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication

16.9

30.8

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

3.7

30.7

143

418

WYA30

SPAT

24.6

30.6

T50.9

ICD-10 Finland

Poisoning: Other and unspecified drugs, medicaments and biological substances

19.8

30.6

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

10.2

30.6

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

8.6

30.5

F31.8

ICD-10 Finland

Other bipolar affective disorders

6.7

30.5

123

R52.1

ICD-10 Finland

Chronic intractable pain

17.1

30.3

F13.9

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, unspecified mental and behavioural disorder

+∞

30.3

T40.1

ICD-10 Finland

Poisoning: Heroin

+∞

30.3

J20

ICD-10 Finland

Acute bronchitis

3.4

30.1

155

491

K04.09

ICD-10 Finland

Pulpit UNS

4.0

30.0

127

342

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

3.3

30.0

164

544

N30.0

ICD-10 Finland

Acute cystitis

3.0

29.9

192

711

Z04.0

ICD-10 Finland

Blood-alcohol and blood-drug test

35.5

29.7

N05AX13

ATC

paliperidone; systemic

16.0

29.6

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

3.2

29.4

164

550

O04.9

ICD-10 Finland

Medical abortion, complete or unspecified, without complication

3.1

29.4

180

645

QCB10

NOMESCO Finland

Major dressing of wound of skin of upper limb

7.9

29.3

Y19

ICD-10 Finland

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

22.7

29.3

SPAT1241

SPAT

Extensive assessment of psychosocial situation

7.5

29.2

Z72.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3011288) Drugs identified in Urine by Screen method

844

770

23.06

307.65

19.9

1.6

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

876

2256

7.69

307.65

3.7

1.7

1.6

1.4

22.46

790

2057

(3027008) Opiates [Presence] in Urine

827

1202

13.71

307.65

15.0

1.3

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

801

901

17.45

307.65

14.4

1.4

—

(3028300) Cannabinoids [Presence] in Urine

830

1206

13.77

307.65

15.7

1.4

—

(3028707) Methadone [Presence] in Urine by Screen method

725

421

31.67

307.65

14.3

1.5

—

(3000764) Benzodiazepines [Presence] in Urine

828

1191

13.88

307.65

15.4

1.3

—

(3027944) Amphetamines [Presence] in Urine

785

1183

12.50

307.65

14.1

1.3

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

457

80.83

307.65

2.2

1.3

—

(3016879) Cocaine [Presence] in Urine

826

1103

15.01

307.65

15.1

1.3

—

(4198724)

292

48.47

307.65

4.4

1.3

—

(3009508) Creatinine [Moles/volume] in Urine

932

2870

6.70

307.58

15.7

3.0

mmol/l

7.1

9.0

19.64

808

2487

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1104

3991

7.25

304.14

5.2

3.2

u/l

63.2

31.7

1.49

1033

3801

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1206

5066

7.38

270.25

7.9

5.7

umol/l

9.9

11.1

2.14

1146

4797

(3023368) Bacteria identified in Blood by Culture

773

2250

5.89

263.72

9.2

3.9

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

455

891

6.83

235.56

5.1

2.7

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

290

343

10.19

233.62

2.1

1.3

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

197

132

16.97

227.64

7.1

1.3

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

985

3884

5.27

224.02

5.7

5.0

g/l

35.9

37.3

9.45

921

3639

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

223

289.39

223.60

1.2

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

232

233

11.55

209.63

1.3

1.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

233

248

10.89

201.93

1.3

1.1

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

703

2280

4.84

200.49

2.2

1.7

—

(3042517) Benzodiazepines panel - Urine

192

243.44

190.11

5.9

1.6

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

928

3832

4.58

189.55

8.4

5.7

mmol/l

1.2

9.93

847

3517

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

742

2644

4.49

184.00

3.9

2.0

u/l

538.1

293.9

0.91

707

2511

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

843

3362

4.33

177.64

2.3

1.7

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

966

4286

4.37

174.31

3.1

2.1

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1380

8046

7.92

173.31

11.6

6.9

u/l

80.0

73.4

9.35

1329

7599

(3033658) Prothrombin time (PT) actual/Normal

713

2563

4.32

172.56

6.2

4.0

90.0

94.3

5.17

684

2496

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

961

4297

4.29

170.29

9.2

6.2

mmol/l

1.2

12.44

813

3654

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

484

1333

4.84

165.68

2.4

1.7

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

522

1533

4.64

164.54

1.9

1.5

—

(3002032) Base excess in Venous blood by calculation

343

709

5.94

163.83

4.3

3.7

mmol/l

2.0

1.8

0.40

271

580

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

366

809

5.62

162.33

2.4

g/l

0.2

12.47

319

751

(42870588) Differential panel, method unspecified - Blood

852

3593

4.07

161.99

7.3

6.3

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

343

717

5.87

161.73

4.3

3.7

kpa

6.2

5.9

4.61

319

699

(3013826) Glucose [Moles/volume] in Serum or Plasma

1131

5855

4.51

158.69

9.0

4.5

mmol/l

6.5

0.18

1081

5351

(3020191) Ethanol [Moles/volume] in Serum or Plasma

150

117

14.10

158.32

2.2

1.5

promille

1.2

1.4

0.46

114

(3014111) Lactate [Moles/volume] in Serum or Plasma

337

734

5.60

151.29

9.4

7.6

mmol/l

1.3

1.4

0.88

319

707

(3032080) INR in Blood by Coagulation assay

791

3315

3.85

148.58

7.9

6.2

inr

1.1

1.01

272

1116

(3023183) Ammonium ion [Moles/volume] in Plasma

168

179

10.41

144.39

2.2

3.4

umol/l

39.0

34.9

0.35

153

156

(3024354) Oxygen [Partial pressure] in Venous blood

293

585

5.95

144.28

3.7

3.0

kpa

5.2

4.8

2.15

267

568

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

144

127

12.41

140.71

1.2

1.1

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

745

3109

3.71

138.62

4.3

2.6

u/l

49.5

56.7

2.97

675

2904

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

201

286

7.93

137.08

2.3

ug/l

402.4

309.7

0.27

188

266

(3042936) Bacteria identified in Isolate by Culture

460

1392

4.29

136.52

2.9

2.1

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

359

914

4.82

133.03

2.3

1.7

—

(3003396) Base excess in Arterial blood by calculation

346

858

4.91

132.39

10.7

8.8

mmol/l

1.5

0.8

2.13

296

659

(3000991) Gas panel - Venous blood

303

672

5.37

132.28

11.4

9.2

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

233

407

6.57

131.14

4.2

3.7

mmol/l

24.5

24.1

0.91

203

372

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

21.09

129.88

2.7

3.7

umol/l

140.6

137.6

0.02

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

357

934

4.67

127.48

2.3

1.7

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

1142

6497

3.94

126.74

16.6

8.9

e9/l

4.3

4.0

4.27

1027

5737

(3019309) Folate [Moles/volume] in Red Blood Cells

421

1263

4.21

125.37

1.9

1.6

nmol/l

1123.9

1161.5

0.31

324

998

(3006315) Basophils [#/volume] in Blood

1052

5713

3.66

124.73

8.9

6.2

e9/l

0.0

1.41

926

5048

(3001604) Monocytes [#/volume] in Blood

1047

5702

3.62

122.83

9.0

6.1

e9/l

0.6

3.18

926

5045

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

336

863

4.70

122.46

10.8

8.8

kpa

5.6

5.0

17.40

324

821

(3027801) Oxygen [Partial pressure] in Arterial blood

336

863

4.70

122.46

10.8

8.8

kpa

10.9

13.4

15.62

325

825

(3013115) Eosinophils [#/volume] in Blood

1063

5904

3.59

119.49

10.4

6.4

e9/l

0.2

0.79

939

5308

(3019150) Specific gravity of Urine by Refractometry

598

2342

3.54

119.41

9.6

3.0

kg/l

1.0

0.34

311

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

223

410

6.19

118.80

1.9

1.5

—

(3016502) Oxygen saturation in Arterial blood

306

755

4.81

116.92

11.4

9.5

94.4

96.6

6.39

297

728

(3022096) Basophils/100 leukocytes in Blood

967

5174

3.34

113.35

8.9

6.3

0.6

0.7

5.17

915

4912

(3019198) Lymphocytes [#/volume] in Blood

1056

5961

3.46

112.98

9.0

6.1

e9/l

2.2

2.0

5.95

934

5377

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

731

3329

3.28

112.65

2.2

1.7

pmol/l

93.7

97.3

1.27

426

1860

(3006504) Eosinophils/100 leukocytes in Blood

980

5362

3.28

109.01

8.8

6.1

2.6

2.8

1.79

931

5081

(3019069) Monocytes/100 leukocytes in Blood

984

5408

3.27

108.39

9.0

6.4

8.1

8.3

1.61

935

5163

(3002173) Hemoglobin [Mass/volume] in Arterial blood

284

720

4.61

104.24

12.1

9.9

g/l

122.6

126.0

1.69

276

691

(3007853) Bacteria identified in Skin by Aerobe culture

393

1267

3.82

103.86

2.3

1.6

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

345

1018

4.08

103.45

10.2

7.5

mmol/l

104.1

104.5

0.72

329

995

(3021960) Folate [Moles/volume] in Serum or Plasma

480

1777

3.47

102.51

1.7

1.4

nmol/l

16.5

20.0

6.64

427

1560

(40758558) Short blood count panel - Blood

615

2651

3.20

101.97

10.8

7.0

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

271

674

4.67

101.77

1.7

1.4

—

(3018418) pH of Serum or Plasma

601

2562

3.21

101.48

4.0

7.4

1.92

137

496

(3012095) Magnesium [Moles/volume] in Serum or Plasma

419

1430

3.65

101.46

4.6

3.7

mmol/l

0.8

1.29

384

1358

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

347

1045

4.00

100.93

3.2

2.6

u/l

27.0

34.1

2.52

301

902

(3009466) Valproate [Moles/volume] in Serum or Plasma

147

211

7.60

98.79

5.1

5.4

umol/l

355.0

386.1

0.85

119

182

(3002030) Lymphocytes/100 leukocytes in Blood

989

5670

3.08

96.90

8.9

6.0

29.7

29.5

0.14

932

5398

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1344

9339

4.47

93.82

7.5

2.8

u/l

56.5

41.4

7.31

1293

8975

(3003458) Phosphate [Moles/volume] in Serum or Plasma

346

1091

3.80

93.66

6.7

6.6

mmol/l

1.1

1.0

2.47

326

1028

(3018010) Neutrophils/100 leukocytes in Blood

970

5592

2.99

92.36

8.8

5.9

55.5

56.2

1.03

921

5335

(3021589) Normoblasts [#/volume] in Blood

905

5048

2.92

91.27

15.2

8.4

e9/l

0.0

0.10

764

4118

(3030467) Casts [#/volume] in Urine by Automated count

583

2610

2.99

88.01

3.7

2.8

e6/l

0.5

0.3

1.00

455

1908

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

196

423

5.16

86.80

1.3

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

218

522

4.70

85.19

1.9

1.5

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

615

2897

2.87

83.66

2.9

3.0

mmol/l

2.3

2.4

1.61

539

2615

(3020779) Urea [Moles/volume] in Serum or Plasma

263

737

4.10

83.61

7.6

8.9

mmol/l

7.3

7.9

0.87

247

709

(3002582) Erythrocytes [#/volume] in Urine

611

2871

2.87

83.48

3.9

2.9

e6/l

37.7

120.9

1.04

479

2154

(36304419) Bacteria [Presence] in Urine

568

2624

2.85

79.39

3.6

2.7

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

107

9.50

79.14

6.3

6.0

mg/l

9.4

9.7

0.20

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

186

415

4.96

79.00

13.5

10.9

mmol/l

24.9

24.1

2.39

172

395

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

673

3409

2.73

78.43

4.0

2.9

—

(3018095) Leukocytes [#/volume] in Urine

688

3544

2.70

77.26

4.4

3.3

e6/l

64.9

65.2

0.01

493

2347

(3031040) Bacteria [#/volume] in Urine by Automated count

1070

6884

2.82

76.14

6.2

3.6

e6/l

404.8

1007.4

0.41

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

339

1208

3.32

74.54

3.3

2.9

umol/l

7.6

7.1

0.16

266

1032

(3010421) pH of Blood

134

243

5.94

71.54

5.1

3.3

7.4

4.12

116

204

(3026008) Bacteria identified in Urine by Culture

507

2324

2.76

70.53

4.1

2.4

—

(3012501) Base excess in Blood by calculation

122

206

6.35

70.01

5.2

3.2

mmol/l

2.6

2.2

0.92

137

(3027945) Reticulocytes/100 erythrocytes in Blood

252

773

3.70

69.74

2.3

3.1

1.8

0.05

219

697

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

177

422

4.61

69.08

12.5

11.5

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

11.05

68.50

2.1

2.4

nmol/l

127.3

151.0

0.97

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

494

2274

2.73

67.72

2.7

2.1

mg/l

3.1

2.7

3.04

419

1984

(3022217) INR in Platelet poor plasma by Coagulation assay

258

826

3.55

66.77

9.6

14.3

inr

1.1

1.2

0.68

129

(3009343) pH of Capillary blood

187

480

4.30

66.30

3.8

2.8

7.4

0.76

(3026782) Osmolality of Urine

426

1841

2.82

65.76

3.5

2.5

mosm/kgh2o

507.9

566.9

5.22

392

1578

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

225

665

3.79

65.58

1.4

1.3

miu/ml

205.4

234.6

0.43

332

(3000850) Epithelial cells [#/volume] in Urine

441

1945

2.78

65.42

3.5

2.4

e6/l

13.5

6.0

1.22

407

1716

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

187

487

4.23

65.00

3.9

2.8

kpa

5.6

5.1

7.13

175

455

(3019550) Sodium [Moles/volume] in Serum or Plasma

1455

11581

5.70

64.95

30.8

10.4

mmol/l

138.9

139.6

23.21

1430

11253

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

181

462

4.31

64.60

3.7

2.8

mmol/l

2.5

1.3

3.52

141

329

(3004982) Buprenorphine [Mass/volume] in Serum or Plasma

+∞

64.00

2.8

0.0

ug/l

2.5

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

21.51

63.94

4.4

1.8

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

1456

11639

5.65

63.57

30.8

10.5

mmol/l

4.0

3.9

1.56

1428

11289

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

632

3368

2.49

63.04

6.1

2.8

ng/l

26.4

34.7

0.57

424

1715

(1616796) Gas panel - Central venous blood

113

196

6.14

63.04

4.7

2.9

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

392

1666

2.82

62.05

4.4

3.0

ng/l

90.5

530.5

3.36

239

1035

(3019060) Gas panel - Arterial blood

178

474

4.12

59.90

6.1

5.9

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

125

261

5.12

56.99

2.9

2.0

ug/l

1.9

2.6

0.24

113

239

(3023520) Reticulocytes [#/volume] in Blood

178

495

3.94

56.31

2.1

3.2

e9/l

74.4

0.00

124

358

(3004119) Hemoglobin [Mass/volume] in Venous blood

172

469

4.00

55.92

3.7

3.1

g/l

131.4

135.2

1.14

165

461

(3008152) Bicarbonate [Moles/volume] in Arterial blood

169

455

4.05

55.92

9.0

8.3

mmol/l

25.8

24.3

4.52

160

421

(3015235) Bicarbonate [Moles/volume] in Capillary blood

104

187

5.89

55.83

3.9

2.3

mmol/l

25.9

24.4

2.26

165

(3007566) Smooth muscle Ab [Titer] in Serum

152

384

4.28

54.76

1.2

1.4

titre

115.2

78.8

0.60

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

127

6.94

53.45

12.5

10.6

mmol/l

0.6

0.03

115

(3023511) Choriogonadotropin [Units/volume] in Urine

168

469

3.90

52.76

1.8

1.3

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

145

6.45

52.75

1.7

1.6

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

146

372

4.23

51.96

3.3

2.6

0.6

0.7

0.53

137

360

(3013707) Erythrocyte sedimentation rate by Westergren method

1122

8095

2.42

51.61

4.5

3.6

mm/h

12.6

8.2

19.00

1031

7591

(3008402) Methanol [Moles/volume] in Serum or Plasma

33.70

51.36

1.2

1.6

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

33.70

51.36

1.2

1.8

—

(40767503) Oxygen content in Capillary blood by calculation

171

5.86

50.90

3.5

2.0

16.4

17.4

1.07

(3021901) Oxygen saturation in Capillary blood

126

6.73

50.17

3.1

2.0

—

(3024928) Oxygen saturation in Venous blood

182

5.56

48.66

2.4

2.7

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

335

1470

2.63

48.59

2.8

2.5

e6/l

3.9

2.3

1.72

149

737

(3013512) EKG study

446

2240

2.40

48.39

4.5

2.8

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1193

8977

2.46

47.73

5.0

3.6

pmol/l

14.5

0.01

1084

8329

(3028626) Oxygen [Partial pressure] in Capillary blood

160

5.84

47.72

3.2

2.0

kpa

8.3

8.5

0.43

152

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

25.92

47.19

6.1

11.2

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

341

1537

2.57

46.62

2.7

2.4

e6/l

1.5

1.2

0.31

159

803

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

464

2410

2.32

46.29

3.4

2.0

—

(3044640) Blood type and Crossmatch panel - Blood

569

3220

2.22

46.10

3.7

2.1

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

316

1400

2.58

44.60

2.5

2.7

mmol/l

2.4

1.44

263

1218

(3037467) Urinalysis macro (dipstick) panel - Urine

1056

7676

2.20

43.80

5.2

3.6

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

305

1340

2.59

43.73

2.3

2.5

29.7

29.6

0.09

291

1303

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1334

10747

2.81

43.27

6.3

4.1

mu/l

1.6

2.0

1.67

1244

10134

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

233

903

2.86

42.64

2.5

4.6

u/l

232.3

232.4

0.00

218

860

(3027273) Bicarbonate [Moles/volume] in Venous blood

127

338

4.01

42.46

4.0

3.4

mmol/l

25.3

25.0

0.44

119

329

(3017509) Phencyclidine [Presence] in Urine

17.03

41.95

4.1

1.1

—

(3052851) Hemolysis interference index of Serum or Plasma

111

275

4.27

40.84

3.2

3.0

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

681

4283

2.06

40.58

2.7

2.2

nmol/l

63.5

72.0

14.08

619

4010

(21494755) Public health laboratory ask at order entry panel

2368

0.16

40.45

1.2

1.3

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

107

260

4.35

40.37

2.0

1.6

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1443

12261

3.84

40.16

29.5

10.2

mg/l

24.3

21.1

3.53

1289

9313

(3004789) Transferrin [Mass/volume] in Serum or Plasma

289

1285

2.54

40.14

2.5

2.3

g/l

2.5

2.4

0.80

258

1191

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

467

2566

2.18

39.63

2.1

1.9

mg/l

1.2

0.9

1.41

351

1819

(1761868) Lipid panel - Serum or Plasma

279

5363

0.41

39.28

3.1

2.2

—

(3044889) 12 lead EKG panel

990

7215

2.04

38.09

4.4

2.9

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

344

1711

2.30

36.93

3.3

3.1

ng/l

1219.6

895.5

0.50

277

1347

(3020891) Body temperature

111

297

3.95

36.77

6.3

4.4

—

(3022948) Iron [Moles/volume] in Serum or Plasma

296

1384

2.41

36.60

2.5

2.3

umol/l

12.3

14.8

5.38

273

1290

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

263

1180

2.48

35.53

2.6

2.4

20.0

25.2

5.28

222

1036

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

212

4.39

34.41

2.7

2.8

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

247

1092

2.50

34.37

2.5

2.0

nmol/l

330.3

365.7

2.06

216

1032

(3019225) pH of Specimen

192

750

2.78

34.29

4.0

3.4

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

1342

11218

2.53

33.51

22.6

8.8

ml/min/173m2

100.6

94.9

16.23

1164

9055

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

743

5044

1.91

33.49

5.6

3.8

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

167

613

2.93

33.45

2.3

1.7

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

342

1767

2.20

33.11

1.9

1.6

pmol/l

462.6

35419778.7

2.15

280

1550

(3022313) Gas panel - Capillary blood

115

340

3.57

32.92

3.8

2.9

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1892

0.17

30.79

1.3

1.6

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

187

4.40

30.78

2.9

2.1

g/l

130.2

135.1

0.81

134

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

171

667

2.76

30.51

5.6

3.5

mmol/l

1.2

4.01

145

580

(3043409) Potassium [Moles/volume] in Arterial blood

216

4.11

30.18

5.0

4.4

mmol/l

3.8

0.34

201

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

191

4.31

29.95

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

191

4.31

29.95

1.4

1.3

—

(3037522) Nuclear Ab [Titer] in Serum

318

1656

2.16

29.88

1.3

1.4

titre

232.4

487.8

6.08

292

(3005719) IgG [Mass/volume] in Serum or Plasma

210

918

2.49

29.71

2.2

2.5

g/l

11.8

10.6

3.13

198

829

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

210

924

2.47

29.28

3.3

2.6

u/l

4290.0

5202.1

0.18

380

(3017446) Testosterone [Moles/volume] in Serum or Plasma

281

1405

2.22

29.17

3.5

2.3

nmol/l

11.7

14.1

5.38

235

1306

(3009214) Lutropin [Units/volume] in Serum or Plasma

167

672

2.67

27.97

1.6

1.4

u/l

7.2

7.1

0.05

112

555

(3003181) Sodium [Moles/volume] in Urine

5.76

27.51

2.1

1.3

mmol/l

69.7

70.0

0.01

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

101

313

3.38

26.85

1.7

2.1

g/l

1.6

1.4

1.45

279

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1467

13140

3.49

26.32

18.1

8.2

u/l

40.8

30.0

8.05

1438

12780

(3021387) Prolactin [Units/volume] in Serum or Plasma

186

818

2.45

25.83

1.8

1.6

mu/l

510.7

283.0

4.67

154

744

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

253

3.58

25.50

1.6

1.5

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

145

570

2.70

25.38

5.2

2.2

ug/l

12.3

9.4

0.33

130

518

(3028026) IgM [Mass/volume] in Serum or Plasma

169

717

2.52

25.33

1.4

1.8

g/l

1.6

1.2

3.08

161

659

(3047181) Lactate [Moles/volume] in Blood

255

3.56

25.20

8.5

7.7

mmol/l

1.1

1.2

0.23

218

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

213

1010

2.29

24.89

9.2

5.3

—

(40761536) Microorganisms panel - Urine sediment

209

987

2.29

24.65

5.3

3.2

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

228

3.65

24.16

1.7

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

5.19

24.11

2.7

1.9

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

469

2989

1.82

23.80

2.7

2.1

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

296

3.24

23.02

7.7

6.9

2.8

1.7

5.37

275

(3007930) Methemoglobin/Hemoglobin.total in Blood

291

3.26

22.99

7.9

7.0

1.0

0.9

0.83

272

(3011397) Hemoglobin [Presence] in Urine by Test strip

390

2371

1.86

22.92

3.9

3.0

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

149

4.22

22.83

1.6

1.7

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

125

488

2.70

22.13

2.7

2.9

ng/l

117.4

132.3

0.19

107

413

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1311

0.17

21.13

1.2

1.3

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

232

3.39

20.68

1.8

1.7

—

(3000494) Fungus identified in Specimen by Culture

240

1283

2.03

20.43

1.5

1.4

—

(3019977) pH of Arterial blood

7.56

20.40

4.1

4.0

7.4

—

(3008295) Osmolality of Serum or Plasma

4.76

20.16

2.1

1.7

mosm/kgh2o

284.2

285.7

0.16

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

221

3.42

20.13

1.6

1.3

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

332

2.95

20.06

2.4

1.8

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

490

3293

1.72

20.03

2.8

2.2

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

152

3.93

19.76

1.8

—

(3037121) Protein [Mass/volume] in Urine

321

2.95

19.46

3.0

3.6

g/l

0.2

0.4

0.36

158

(3000570) Elastase.pancreatic [Mass/mass] in Stool

257

3.19

19.41

1.6

1.4

ug/g

252.1

318.9

1.69

139

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

138

603

2.42

19.31

2.1

1.9

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

5.39

19.25

4.3

3.8

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

5.24

19.16

11.6

8.2

u/ml

2964.8

22778.9

0.41

(3002385) Erythrocyte distribution width [Ratio]

1241

10694

1.83

19.11

35.7

12.4

13.9

13.3

29.89

1226

10491

(3044290) Cell count panel - Cerebral spinal fluid

272

3.09

18.87

2.0

1.6

—

(3029937) Albumin [Presence] in Urine by Test strip

433

2855

1.72

18.76

5.4

3.2

estimate

0.0

1.49

198

1074

(3002179) Metamyelocytes/100 leukocytes in Blood

166

799

2.21

18.52

4.2

4.3

0.6

0.5

0.23

173

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1260

10955

1.83

18.21

5.0

3.3

mmol/l

6.1

5.7

7.89

1153

10272

(3017181) Myelocytes/100 leukocytes in Blood

173

856

2.15

18.00

4.5

0.6

0.8

0.59

220

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

304

2.90

17.74

2.5

1.7

—

(40768797) Stomach Pathology biopsy report

229

1281

1.93

16.94

1.3

1.2

—

(3021440) Promyelocytes/100 leukocytes in Blood

164

820

2.12

16.57

4.6

4.5

0.0

0.1

2.50

207

(3035350) Ketones [Presence] in Urine by Test strip

722

5551

1.57

16.24

4.6

3.0

estimate

0.0

0.50

205

1061

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

150

730

2.17

16.24

2.6

1.9

nmol/l

46.4

35.4

5.03

138

723

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

105

4.18

16.13

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

105

4.18

16.13

1.0

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

8.17

15.78

5.1

2.7

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

8.17

15.78

5.1

2.7

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

112

4.01

15.63

1.1

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

287

2.81

15.47

2.1

1.5

e6/l

24.2

14.7

0.38

229

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

287

2.81

15.47

2.1

1.6

e6/l

50357.3

1075.7

0.49

235

(40761511) CBC panel - Blood by Automated count

1430

13134

2.25

15.39

25.0

9.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

119

2380

0.46

15.32

1.4

1.5

—

(3001019) Free T4 and TSH panel - Serum or Plasma

967

0.18

15.31

1.3

1.6

—

(3021601) Nitrite [Presence] in Urine by Test strip

716

5558

1.54

15.03

5.7

4.1

estimate

0.0

0.50

206

1108

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

147

732

2.11

14.99

2.4

3.4

pmol/l

4.4

4.7

2.20

121

665

(3009261) Glucose [Presence] in Urine by Test strip

719

5600

1.53

14.77

4.6

3.0

estimate

0.0

0.80

202

1048

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

132

3.64

14.56

2.0

1.8

—

(3034770) Mitochondria Ab [Titer] in Serum

389

2.48

14.30

1.2

1.4

—

1440.0

—

(3011648) Oxygen content in Venous blood

4.55

14.28

1.9

2.2

11.4

12.1

0.34

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

5.89

14.01

3.5

1.8

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

30.33

13.89

2.4

2.0

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

144

3.41

13.48

1.3

2.0

nmol/l

18.3

21.3

1.49

137

(3012516) Albumin [Mass/volume] in Urine

334

2230

1.64

13.16

3.2

3.4

mg/l

87.5

333.9

2.14

197

1527

(3023419) Bacteria identified in Sputum by Culture

4.07

13.13

1.9

2.7

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

4.69

13.09

1.2

1.1

iu/ml

280.8

224.5

0.44

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

406

2.37

13.03

1.8

2.6

89.1

95.3

1.52

385

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

383

2655

1.59

12.89

1.7

1.6

mmol/l

1.8

1.5

4.56

322

2331

(40760892) CBC W Ordered Manual Differential panel - Blood

419

2968

1.57

12.84

6.6

4.3

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

281

2.64

12.78

1.3

1.4

mmol/l

3.9

3.6

1.14

264

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

101

3.83

12.76

2.2

2.7

e6/l

949.8

828.6

—

(40761535) Cells panel - Urine sediment

133

678

2.05

12.73

4.1

3.1

—

(3016018) Differential panel - Cerebral spinal fluid

130

3.45

12.66

2.5

1.6

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

3.88

12.66

1.3

1.6

mmol/l

1.9

1.8

0.17

(3025159) Blasts/100 leukocytes in Blood

149

795

1.97

12.55

4.8

4.6

0.0

0.2

1.43

181

(3007164) IgA [Mass/volume] in Serum or Plasma

387

2704

1.58

12.54

1.5

1.4

g/l

2.3

0.13

243

1820

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

204

2.92

12.52

2.9

4.7

u/ml

0.3

0.10

108

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

20.22

12.46

2.4

1.8

—

(40757494) Bilirubin.total [Moles/volume] in Blood

5.17

12.23

1.9

2.1

umol/l

11.6

17.0

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

4.31

12.22

1.9

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

4.66

12.14

1.2

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

4.66

12.14

1.2

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

4.66

12.14

1.2

1.6

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

689

5466

1.47

12.12

3.3

2.8

ug/l

95.8

103.2

0.50

623

5178

(3020630) Protein [Mass/volume] in Serum or Plasma

109

525

2.16

12.10

1.8

2.2

g/l

67.3

68.0

0.31

494

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

111

3.58

11.88

1.7

1.5

—

(3023410) Appearance of Cerebral spinal fluid

131

3.35

11.82

2.5

1.8

—

(3020682) Albumin/Creatinine [Ratio] in Urine

340

2339

1.58

11.68

4.4

4.2

mg/mmol

18.2

11.6

0.78

193

1572

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

235

2.71

11.67

1.5

1.4

u/l

15.8

14.6

0.13

200

(3036489) Thrombin time

456

2.20

11.45

1.9

2.5

21.4

21.0

0.50

403

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

166

3.02

11.32

1.8

1.6

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

284

1889

1.62

11.19

1.3

iu/ml

31.6

22.3

0.71

561

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

117

3.39

10.99

2.0

1.9

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

138

3.18

10.89

1.7

1.5

—

(3035637) Corticotropin [Mass/volume] in Plasma

123

3.31

10.85

1.4

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1152

10237

1.50

10.44

5.6

4.2

mmol/mol

38.6

38.0

0.89

1046

9762

(3004588) Protein electrophoresis panel - Serum or Plasma

402

2.21

10.31

1.5

1.8

—

(3000093) Morphology [Interpretation] in Blood Narrative

3.85

10.24

1.3

1.2

—

(3004809) Band form neutrophils/100 leukocytes in Blood

128

3.18

10.19

2.5

2.9

1.9

1.2

0.43

110

(3023199) Leukocytes [#/volume] in Pleural fluid

4.84

10.02

1.6

1.2

e6/l

3724.7

2326.2

0.45

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

104

532

2.02

9.87

3.2

4.5

ng/l

81.1

82.2

0.04

491

(3028308) Erythrocytes [#/volume] in Pleural fluid

5.18

9.85

1.7

1.3

e6/l

14800.9

22135.6

0.29

(3044242) Glucose [Moles/volume] in Arterial blood

4.94

9.80

4.1

3.0

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

3.71

9.73

2.5

3.0

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

3.91

9.42

2.6

2.2

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

6.58

9.36

3.4

4.8

—

(3012441) Differential panel - Pleural fluid

4.72

9.31

1.7

1.2

—

(3006653) Thiamine [Moles/volume] in Blood

4.45

9.09

1.1

1.4

nmol/l

152.0

148.2

0.09

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

207

2.56

8.94

1.7

1.6

g/l

12.4

10.5

1.23

188

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

3.35

8.92

1.1

1.4

—

44.0

—

(4010399)

118

655

1.87

8.83

1.4

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

4.70

8.83

1.4

2.0

umol/l

9.5

14.9

1.68

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

180

2.66

8.74

1.7

1.6

g/l

38.9

38.6

0.09

164

(3042631) Mycobacterium sp identified in Specimen

3.50

8.66

3.0

2.8

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

225

2.45

8.46

1.7

1.6

g/l

3.6

3.8

0.89

171

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

225

2.45

8.46

1.7

1.6

g/l

7.3

7.2

0.18

181

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

225

2.45

8.46

1.7

1.6

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

213

2.49

8.45

1.6

g/l

3.1

0.02

177

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1372

0.48

8.42

1.3

1.5

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

4.33

8.41

1.0

1.1

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

155

2.76

8.39

1.1

1.7

—

(3045788) Cell count panel - Pleural fluid

4.91

8.37

1.7

1.3

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

4.68

8.36

1.4

1.3

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

253

1747

1.54

8.32

2.4

2.1

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

3.55

8.26

1.2

1.1

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

326

2.17

8.11

3.6

3.1

mg/l

1.6

1.3

1.81

306

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

206

1376

1.57

7.83

2.2

2.0

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

3.20

7.83

1.8

1.6

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

193

2.48

7.62

1.7

g/l

0.1

0.7

1.51

181

(43055514) Macroprolactin [Presence] in Serum or Plasma

4.00

7.62

1.2

1.3

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

118

2.92

7.61

2.0

1.7

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

3.83

7.53

1.1

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

4.43

7.43

1.4

1.3

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

143

2.70

7.35

1.1

1.2

u/l

109.4

40.4

0.48

124

(3051611) Lipemic interference index of Serum or Plasma

3.29

7.12

3.0

4.1

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

4.08

7.09

4.3

1.5

umol/l

29.1

28.6

0.08

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

396

3075

1.39

6.92

1.3

u/ml

1.8

1.7

0.02

879

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

369

2.00

6.87

1.4

1.8

—

287.3

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

3.21

6.86

1.6

1.7

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

3.28

6.84

2.4

2.6

54.1

57.1

0.20

(44790047)

120

2.79

6.82

1.6

1.8

—

(44806118)

120

2.79

6.82

1.6

1.8

—

(44790049)

120

2.79

6.82

1.6

1.8

—

(44790048)

120

2.79

6.82

1.6

1.8

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

155

2.56

6.80

2.3

2.8

ratio

1.1

2.0

—

(3039443) Prostate specific Ag panel - Serum or Plasma

314

0.19

6.72

1.3

1.5

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

156

2.54

6.71

2.3

2.8

mg/l

35.7

92.5

0.75

123

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

156

2.54

6.71

2.3

2.8

mg/l

30.0

33.1

0.22

121

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

273

2.13

6.53

4.2

6.6

iu/ml

138.2

895.4

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

4.36

6.50

1.3

1.6

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

4.36

6.50

1.3

1.6

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

4.36

6.50

1.3

1.6

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

4.36

6.50

1.3

1.6

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

3.67

6.48

1.1

2.5

ug/l

1.1

1.2

0.01

(40760888) Immunoglobulin light chains.free panel - Serum

118

2.75

6.46

2.3

3.1

—

(3007461) Platelets [#/volume] in Blood

1481

14274

2.00

6.41

42.9

14.6

e9/l

252.8

254.4

0.39

1459

13972

(3026480) Teichoate Ab [Titer] in Serum

14.37

6.40

1.1

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

14.37

6.40

2.9

1.0

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

4.08

6.36

1.2

u/l

35.5

30.3

0.08

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

283

2.09

6.34

1.3

1.5

—

3.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

4.85

5.98

1.3

1.8

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

4.85

5.98

1.3

1.8

—

(3035941) MCH [Entitic mass]

1481

14301

1.94

5.95

42.7

14.5

29.9

30.1

2.71

1470

14145

(3024731) MCV [Entitic volume]

1481

14302

1.94

5.93

42.7

14.5

89.7

89.6

0.26

1470

14148

(3027974) Hepatitis B virus e Ag [Presence] in Serum

15.07

5.90

1.0

1.5

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

124

2.61

5.90

1.3

—

(3026361) Erythrocytes [#/volume] in Blood

1481

14305

1.94

5.88

42.8

14.5

e12/l

4.5

4.7

24.94

1455

13989

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

805

0.45

5.80

1.5

—

(3010813) Leukocytes [#/volume] in Blood

1481

14312

1.92

5.77

43.0

14.6

e9/l

7.5

6.6

38.21

1454

13989

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

4.67

5.74

1.4

1.7

—

(3051651) Icteric interference index of Serum or Plasma

3.26

5.73

2.9

4.3

—

(3000963) Hemoglobin [Mass/volume] in Blood

1481

14314

1.92

5.73

43.1

14.6

g/l

134.5

140.6

40.96

1469

14151

(3000475) Leukocytes [#/volume] in Synovial fluid

190

2.24

5.57

1.6

1.8

e6/l

9361.2

16983.4

0.59

140

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

3.02

5.54

1.7

1.5

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

2.92

5.47

1.6

1.7

69.0

55.8

0.66

(3001556) Androgen free Index in Serum or Plasma

4.15

5.36

1.9

1.2

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

240

1784

1.41

5.32

1.3

1.2

u/ml

8.1

8.6

0.05

761

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

126

2.49

5.22

1.4

1.3

nmol/l

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

155

1064

1.51

5.20

3.6

3.3

29.7

29.6

0.03

116

810

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

133

2.44

5.15

1.1

—

(3014271) Vancomycin [Susceptibility]

4.47

5.04

4.3

2.0

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

4.81

5.01

1.3

1.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

771

0.48

4.95

2.2

1.9

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

125

2.43

4.82

2.1

1.2

—

(3021788) Differential panel - Synovial fluid

138

2.35

4.77

1.5

1.7

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

126

2.41

4.74

2.2

1.2

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

126

2.41

4.74

2.1

1.2

—

(3005570) Glucose [Moles/volume] in Urine

2.63

4.74

1.7

2.3

—

(3043410) Blood group antigens tested for on Red Blood Cells

3.96

4.71

3.1

1.3

—

(3009542) Hematocrit [Volume Fraction] of Blood

1315

12463

1.38

4.68

30.7

10.6

39.6

41.6

14.60

880

10530

(3005988) Vibrio sp identified in Specimen by Organism specific culture

127

2.39

4.66

2.1

1.2

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

3.13

4.64

1.9

1.5

22.8

36.6

0.75

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

166

2.20

4.61

1.2

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

128

2.37

4.59

2.2

1.3

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

14.05

4.58

1.0

1.6

—

(3013762) Body weight Measured

10.04

4.52

1.0

1.5

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

3.43

4.47

2.5

1.6

—

(3015183) Erythrocyte sedimentation rate

111

0.00

4.39

0.0

1.2

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

3.74

4.37

1.1

1.5

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

3.36

4.33

2.5

1.6

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

734

0.51

4.31

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

734

0.51

4.31

1.4

1.5

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

733

0.51

4.29

1.4

1.5

—

(3019832) Treponema pallidum Ab [Presence] in Serum

330

2659

1.31

4.29

1.8

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

8.93

4.28

1.0

1.2

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

586

0.45

4.27

1.9

1.7

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

3.89

4.26

2.0

2.2

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

730

0.51

4.24

1.4

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

371

0.32

4.22

1.0

1.1

u/ml

0.2

1.5

—

159

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

3.16

4.21

2.4

1.6

—

(3045716) Anion gap in Serum or Plasma

3.28

4.19

2.4

mmol/l

9.3

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

426

0.37

4.14

1.0

1.1

u/ml

0.5

1.7

—

179

(3024522) Salmonella sp identified in Specimen by Organism specific culture

128

2.29

4.14

2.2

1.3

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

2.55

4.14

1.0

1.1

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

3.77

4.09

1.1

1.0

79.9

102.5

2.26

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

3.77

4.09

1.1

1.0

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

653

0.49

4.04

1.3

1.6

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

217

1.96

4.04

2.2

1.2

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

391

0.35

4.03

1.1

u/ml

4.2

7.1

—

214

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

3.66

3.92

2.3

2.5

umol/l

22.7

28.7

—

(3044941) Cell count panel - Synovial fluid

125

2.26

3.91

1.3

1.5

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

132

2.22

3.87

1.4

1.3

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

627

0.50

3.82

1.5

—

(40768806) Pleura Pathology biopsy report

3.08

3.81

1.6

1.4

—

(3025941) Bacteria identified in Stool by Culture

111

761

1.49

3.80

1.8

1.2

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

378

0.36

3.76

1.0

1.1

u/ml

0.2

2.2

—

102

(3047352) Trisomy 18 risk [Likelihood] in Fetus

608

0.50

3.72

1.4

1.5

—

(3005033) Fetal Nuchal fold Thickness US

606

0.50

3.68

1.4

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

109

750

1.49

3.67

1.4

iu/l

14.8

17.7

0.58

628

(3042111) Morphology [Interpretation] in Bone marrow Narrative

103

2.35

3.67

1.7

2.3

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

2.49

3.64

3.1

3.0

—

(21494890) Protein electrophoresis panel - 24 hour Urine

2.96

3.58

1.1

2.3

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

486

1.59

3.57

1.5

1.7

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

7.81

3.56

1.4

1.2

nmol/l

30.5

14.9

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

221

1.88

3.52

1.0

1.1

iu/ml

31.8

131.5

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

265

1.80

3.51

1.1

1.3

—

(3026389) Candida sp identified in Specimen by Organism specific culture

138

2.12

3.50

1.2

1.3

—

(36660697) Celiac disease serology panel - Serum

146

1078

1.39

3.39

1.1

1.2

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

5.02

3.37

1.0

—

(3000012) Reticulocyte production index

3.46

3.33

1.3

1.8

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

4.76

3.24

1.1

1.0

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

123

2.13

3.21

1.2

1.5

pmol/l

289.2

319.9

0.10

(3050129) First trimester maternal screen panel - Serum or Plasma

887

0.62

3.18

1.3

1.4

—

(4034850)

335

1.67

3.16

12.9

8.0

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

3.09

1.4

1.3

—

64.0

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

3.09

3.5

2.9

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

3.09

1.5

1.2

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

2.36

2.99

3.5

2.3

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

121

2.08

2.93

1.1

mg/l

312.7

269.0

2.03

108

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

3.16

2.93

1.4

1.2

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

3.16

2.93

1.4

1.2

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

2.33

2.91

1.1

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

156

1.94

2.91

1.1

1.0

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

3.35

2.91

1.0

—

(1002224) Polysomnography panel

782

0.61

2.90

1.1

—

(40757373) Influenza virus identified in Isolate

4.11

2.88

1.9

2.4

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

2.52

2.87

2.3

2.2

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

5.40

2.87

1.9

1.0

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

143

1.98

2.86

1.2

1.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

130

2.02

2.81

1.1

1.7

—

(3017569) Oxygen content in Arterial blood

3.07

2.81

1.7

3.6

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

501

4415

1.20

2.80

5.5

2.9

—

(3051593) INR in Capillary blood by Coagulation assay

3.93

2.77

2.1

8.4

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

364

1.59

2.76

1.4

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

364

1.59

2.76

1.4

1.2

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

8.36

2.75

5.4

2.0

umol/l

1.0

1.5

—

(3052592) Norovirus Ag [Presence] in Stool

5.02

2.73

4.1

1.0

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

167

1.87

2.73

1.2

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

212

1.76

2.68

1.5

1.4

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

161

1.88

2.67

1.1

1.0

—

(42529406) Shigella sp [Presence] in Stool by Culture

367

1.57

2.67

1.4

1.2

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

228

1.73

2.64

1.4

1.9

g/l

0.5

0.8

1.58

172

(3014133) Dog dander IgE Ab [Units/volume] in Serum

320

0.43

2.64

1.0

1.1

u/ml

2.1

4.2

—

132

(3011412) CD3 cells [#/volume] in Blood

113

2.05

2.62

2.2

2.8

e9/l

1.1

1.3

—

(3030313) Adrenal Ab [Titer] in Serum

4.68

2.60

1.0

1.1

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

156

1.88

2.57

5.7

2.8

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

452

1.50

2.56

1.1

1.2

u/ml

1.0

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

2.43

2.54

1.2

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

4.39

2.47

1.9

1.7

mmol/l

1.2

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

242

1.67

2.42

1.2

1.3

u/ml

2.5

5.8

1.17

(3010144) Erythrocytes [#/volume] in Synovial fluid

2.30

2.41

1.6

1.3

e6/l

121771.7

23912.5

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

104

2.03

2.36

2.3

1.8

—

(3035880) pH of Pleural fluid

3.65

2.36

1.3

1.2

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

2.62

2.36

1.1

2.2

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

2.62

2.36

1.1

1.0

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

2.62

2.36

1.1

2.2

—

(3003740) Influenza virus B Ag [Presence] in Specimen

371

0.51

2.35

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

370

0.51

2.33

1.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

507

0.58

2.28

1.2

1.5

—

(3026493) Urate [Moles/volume] in Serum or Plasma

298

2547

1.21

2.26

2.5

2.3

umol/l

338.5

4384.7

6.36

245

2313

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

126

980

1.31

2.16

1.3

1.2

iu/ml

77.6

140.2

1.64

396

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

2.11

2.13

2.2

1.7

mg/l

30.4

19.2

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

291

1.56

2.13

1.6

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

3.21

2.09

1.0

1.1

—

(4062490)

131

1.85

2.08

1.4

1.3

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

131

1.85

2.08

1.4

1.3

g/l

0.5

0.3

1.07

(3028192) IgG subclass 2 [Mass/volume] in Serum

131

1.85

2.08

1.4

1.3

g/l

2.6

2.9

0.21

(3027135) IgG subclass 1 [Mass/volume] in Serum

131

1.85

2.08

1.4

1.3

g/l

6.0

6.4

0.18

(3001964) Herpes simplex virus Ag [Presence] in Specimen

2.91

2.07

2.1

2.2

—

(1617658) Protocol used for examination of sentinel lymph nodes

0.00

2.06

0.0

1.0

—

(3008536) Aspergillus sp Ab [Presence] in Serum

4.01

2.04

1.2

2.9

—

(3004616) Nuclear Ab [Presence] in Serum

111

1.90

2.01

1.3

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

599

1.37

1.96

3.0

4.9

ug/l

28.0

28.2

0.00

473

(4015189)

4.56

1.94

2.2

2.6

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

3.19

1.88

1.3

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

442

1.42

1.87

1.3

1.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

2.66

1.86

1.1

—

(4027681)

107

1.88

1.86

1.4

1.3

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

2.51

1.83

2.3

3.5

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

711

1.33

1.83

1.3

1.2

—

(3051339) Copper [Moles/volume] in Blood

4.18

1.82

1.2

1.1

umol/l

15.3

14.4

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

131

1620

0.79

1.82

2.1

ug/l

0.4

0.7

5.42

743

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

372

1.44

1.75

1.9

2.1

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

0.00

1.71

0.0

1.1

—

45.9

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

350

1.44

1.68

1.8

1.9

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

1.68

0.0

1.1

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

2.39

1.68

3.3

2.2

—

88593.6

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

149

1.69

1.67

1.0

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

301

1.48

1.66

1.6

2.0

iu/l

3.5

5.0

0.79

113

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

2.59

1.66

2.7

2.4

—

(3022621) pH of Urine by Test strip

626

1.33

1.66

2.8

2.2

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

1.90

1.65

2.5

1.3

—

65.1

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

750

1.30

1.65

4.2

2.2

ml/min/173m2

73.4

78.8

0.45

279

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

205

1.57

1.63

1.2

—

(3041806) Other cells [#/volume] in Blood by Manual count

134

0.37

1.61

1.6

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

246

1.52

1.61

1.1

3.2

nmol/l

0.9

0.02

216

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

128

1.73

1.60

1.0

1.1

mg/l

222.7

251.4

0.57

105

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

248

0.52

1.58

1.2

1.1

—

16.9

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

2.43

1.54

1.3

1.5

nmol/l

127.5

103.2

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.60

1.51

1.0

1.1

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

2.01

1.49

1.4

1.8

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

285

1.45

1.46

1.5

nmol/l

0.2

0.4

1.88

245

(3000492) Spirometry study

114

1392

0.80

1.45

1.6

1.4

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

2.12

1.44

1.1

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

3.13

1.44

2.0

2.1

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

3.13

1.44

2.6

3.1

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

3.13

1.44

6.6

8.4

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.73

1.43

1.0

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

245

1.48

1.43

1.1

—

(3003327) Ova and parasites identified in Stool by Light microscopy

449

1.35

1.42

1.9

1.8

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

134

1.65

1.39

1.1

mg/l

32.4

38.8

0.65

106

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

524

1.31

1.33

1.8

2.2

u/l

48.6

40.2

1.33

491

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

241

1.46

1.33

1.2

1.3

u/ml

3.3

4.9

0.67

110

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

1.85

1.30

1.3

1.1

—

(3017732) Neutrophils [#/volume] in Blood

796

1.25

1.28

3.5

2.3

e9/l

4.0

4.1

0.32

690

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

2.29

1.27

1.1

1.4

ug/l

9.7

8.5

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

116

0.43

1.25

1.4

1.5

g/l

0.7

1.0

—

116

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

159

0.50

1.25

3.0

2.1

—

(3028433) Virus identified in Specimen by Culture

2.23

1.24

1.3

1.1

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

2.23

1.24

2.5

2.1

ug/l

73.3

54.6

—

(3044927) Protein electrophoresis panel - Urine

1.97

1.22

1.0

1.1

—

(4306422)

238

1.44

1.21

1.2

—

(3037756) Immunofixation for Serum or Plasma

101

1.69

1.20

1.2

1.5

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

323

0.65

1.19

1.3

1.2

ug/l

2.8

3.4

0.36

305

(3035320) C reactive protein [Mass/volume] in Body fluid

1.75

1.19

3.4

1.9

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

2.31

1.18

1.7

1.2

—

(3029075) Extractable nuclear Ab panel - Serum

2.11

1.18

1.0

1.1

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

368

1.34

1.17

1.2

—

(3047189) Immunofixation for 24 hour Urine

2.50

1.15

1.0

1.7

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

2.50

1.15

2.4

5.6

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

353

1.34

1.13

1.2

u/ml

310.9

229.7

1.07

229

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

2.34

1.12

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

257

0.62

1.11

1.4

1.1

—

(4094501)

231

0.60

1.09

1.0

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

2.19

1.08

1.1

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

2.19

1.08

4.9

2.3

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

192

2170

0.87

1.06

3.0

2.8

18.9

21.4

0.61

633

(3041096) Erythrocytes [Presence] in Urine by Automated

367

3373

1.12

1.06

4.5

2.6

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

129

1.56

1.05

1.1

1.0

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

2.13

1.05

1.3

1.6

u/l

18.6

15.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

2.13

1.05

1.1

1.2

—

(40765089) Chromosome analysis panel - Blood by G-banded

122

0.49

1.05

1.0

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

179

0.56

1.05

1.7

1.5

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

131

1521

0.85

1.03

1.7

1.9

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

307

2798

1.12

1.03

3.2

3.0

ug/l

1.1

1.5

2.64

246

2579

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.06

1.03

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.06

1.03

1.1

—

(3044007) Cell count panel - Peritoneal fluid

2.18

0.98

2.6

1.8

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

385

3565

1.11

0.97

1.6

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

1.80

0.96

1.3

1.1

u/l

68.6

90.9

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

337

1.31

0.96

1.7

2.4

mg/l

10.7

10.1

0.14

319

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

191

1.42

0.95

1.2

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.77

0.94

1.6

1.8

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

101

1.59

0.93

1.3

—

(3045142) Bone marrow Pathology biopsy report

1.67

0.91

1.4

—

(3004451) EKG impression Narrative

1.91

0.88

1.6

1.1

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

1.65

0.88

2.2

2.4

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

205

0.63

0.87

2.3

2.5

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

1.82

0.86

1.0

1.1

—

(3003694) ABO and Rh group [Type] in Blood

422

3949

1.09

0.85

1.7

1.6

—

(3014051) Protein [Presence] in Urine by Test strip

204

1.38

0.85

1.5

1.9

—

(21494814) CD8 cells/100 lymphocytes in Specimen

1.78

0.84

3.0

2.2

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

190

0.63

0.83

1.2

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

267

1.32

0.81

1.8

4.3

u/ml

11.9

681.4

0.75

237

(3009871) Measles virus Ab [Titer] in Serum

1.73

0.79

1.2

1.7

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

1.82

0.79

1.7

3.0

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.00

0.79

0.0

1.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

258

0.69

0.78

1.1

1.2

—

(3025130) Human papilloma virus identified in Specimen

208

1.35

0.77

1.8

1.7

—

(3011897) Casein IgE Ab [Units/volume] in Serum

0.00

0.77

0.0

1.1

—

7.7

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

650

1.19

0.77

1.2

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

416

0.76

0.77

1.5

1.3

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.77

0.76

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.77

0.76

1.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.77

0.76

1.0

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.00

0.76

0.0

4.7

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

403

0.76

0.75

1.7

1.5

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

2.09

0.74

1.0

1.1

—

(3000330) Specific gravity of Urine by Test strip

388

1.24

0.73

3.6

2.9

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

219

0.68

0.73

1.1

1.2

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

125

1.45

0.72

1.1

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

389

0.77

0.72

1.2

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

1.55

0.72

1.0

1.2

ratio

1.2

1.1

—

(4268621)

169

1.37

0.69

2.3

2.4

—

(4024509)

1.64

0.68

1.8

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

1.49

0.66

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

1.49

0.66

1.1

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

1.49

0.66

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

1.49

0.66

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

1.49

0.66

1.4

2.0

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1127

11497

0.93

0.66

3.7

3.2

mmol/l

1.5

1.3

9.08

1004

10962

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

213

0.70

0.65

1.0

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

1.48

0.64

1.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

1.48

0.64

1.6

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

1.48

0.64

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

1.48

0.64

1.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

112

1.43

0.63

1.2

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

325

0.77

0.63

1.2

1.1

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1175

11957

0.93

0.62

4.0

3.4

mmol/l

1.3

1.4

25.44

1054

11410

(3010838) Calcium [Moles/time] in 24 hour Urine

1.64

0.62

1.5

1.4

—

7.9

—

(3002256) Pathology report gross observation

135

1214

1.12

0.62

1.3

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

1.46

0.61

1.6

1.2

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.00

0.60

0.0

1.0

—

(3008898) HLA-B27 [Presence]

649

1.16

0.60

1.1

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

266

0.75

0.60

1.1

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

1.46

0.58

2.3

13.6

11.9

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

115

0.61

0.58

1.0

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

812

1.14

0.57

1.4

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

274

1.25

0.57

1.1

1.2

u/ml

5.0

8.9

—

(3024263) Appearance of Synovial fluid

1.62

0.55

1.3

2.1

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.54

0.55

4.5

3.2

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

806

1.14

0.54

1.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.58

0.54

1.2

1.3

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

313

1.22

0.53

1.2

1.4

u/ml

109.9

105.0

—

(40768441) Liver Pathology biopsy report

1.45

0.52

1.0

1.5

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

224

1.25

0.51

5.5

3.3

mg/l

19.4

26.6

0.74

138

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1109

10896

1.06

0.50

3.9

3.6

—

(44813793)

1.43

0.49

1.1

1.0

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

418

1.18

0.49

1.6

1.4

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

326

1.20

0.48

1.2

1.4

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

1.52

0.48

1.0

1.5

u/l

210.9

198.9

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

1.49

0.47

1.1

1.3

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

222

0.76

0.47

1.7

1.3

pmol/l

74.2

112.3

0.37

217

(4211845)

1.43

0.46

2.3

1.9

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

131

1.30

0.42

1.0

1.3

—

50.8

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

332

1.18

0.42

1.2

1.4

—

16.5

—

(1761482) Bacteria [#/volume] in Urine by Culture

176

1.25

0.42

6.0

3.5

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

6.1

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

1.36

0.41

1.4

1.7

u/field

2.1

6.9

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

0.40

0.0

1.0

—

(3048689) Calprotectin [Mass/mass] in Stool

193

1812

1.07

0.40

2.6

2.8

ug/g

163.1

124.4

0.82

158

1471

(3036048) Francisella tularensis Ab [Titer] in Serum

1.47

0.40

1.4

1.1

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

0.00

0.40

0.0

1.8

—

2.7

—

(3045424) Erythrocytes [Presence] in Urine

192

0.78

0.38

1.5

1.4

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

1.33

0.37

2.7

7.5

—

(4146454)

1.31

0.37

1.7

2.8

—

(3006462) Nitrate [Presence] in Urine

1.40

0.35

2.5

1.8

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

1.31

0.33

1.0

1.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.32

0.31

1.0

1.1

—

(21494434) Karyotype in Bone marrow

1.30

0.30

1.7

1.2

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

1.25

0.29

3.9

1.2

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1189

12007

0.96

0.29

4.0

3.4

mmol/l

4.4

4.8

28.73

1074

11482

(4281824)

1.21

0.26

1.4

1.1

—

(3005322) IgE [Units/volume] in Serum or Plasma

859

1.08

0.25

1.6

1.3

u/ml

142.3

265.0

2.19

797

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

213

0.84

0.25

3.1

2.5

ug/min

138.8

124.8

—

136

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

673

0.92

0.24

1.7

mg/l

6.1

3.7

1.28

449

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

1.27

0.24

1.2

1.1

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

466

1.10

0.23

1.6

iu/ml

0.0

0.2

0.96

(3009677) Dengue virus Ab [Presence] in Serum

0.00

0.21

0.0

1.1

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.5

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

0.00

0.21

0.0

1.1

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

0.00

0.21

0.0

14.8

—

161.6

—

(3010937) Rubella virus Ab [Presence] in Serum

0.00

0.21

0.0

1.1

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

0.00

0.20

0.0

1.1

—

(3022145) Colonoscopy Study observation

126

1203

1.05

0.19

1.5

1.4

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

1.24

0.18

3.7

1.3

ug/l

34.2

7.8

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

300

1.10

0.18

2.5

2.3

umol/l

5.2

5.5

0.13

226

(40768446) Kidney Pathology biopsy report

1.17

0.17

1.4

1.5

—

(3049717) Cytology report of Urine Cyto stain

224

1.12

0.17

2.2

2.3

—

(40768804) Tissue Pathology biopsy report

409

4164

0.98

0.15

2.0

1.9

—

(3032773) Endomysium IgG Ab [Titer] in Serum

121

1.16

0.15

1.2

1.0

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

0.81

0.14

1.0

1.2

—

(40768800) Prostate Pathology biopsy report

0.78

0.14

1.1

1.2

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

208

2027

1.03

0.13

1.5

—

(3045414) Leukocytes [Presence] in Urine

446

1.06

0.10

1.6

1.7

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1204

12090

0.98

0.10

4.3

3.6

mmol/l

2.7

2.9

19.48

1073

11487

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

116

1.12

0.09

1.1

1.2

—

(3036071) Salmonella sp Ab [Titer] in Serum

0.82

0.08

1.2

1.1

—

(3034426) Prothrombin time (PT)

0.83

0.08

1.2

1.4

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

0.81

0.08

1.0

1.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

1.08

0.08

1.1

1.2

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

1.06

0.08

2.0

3.3

u/ml

602.9

696.8

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

1.03

0.07

1.1

1.2

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

0.83

0.07

1.0

1.2

—

(4035726)

719

1.03

0.07

1.7

1.4

—

(3003338) MCHC [Mass/volume]

1154

11576

0.99

0.06

38.7

12.4

g/l

333.0

334.9

9.36

1148

11496

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

319

1.04

0.03

1.8

1.9

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

242

1.03

0.02

1.0

1.2

u/ml

25.0

23.1

—

(40768793) Breast Pathology biopsy report

177

0.96

0.01

1.2

—

(40768443) Skin Pathology biopsy report

378

1.01

0.00

1.1

1.2

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.00

0.0

2.7

—

(3051101) Glucose [Moles/volume] in Cord blood

0.00

0.0

5.3

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.0

1.0

—

(3034614) HLA Ag [Interpretation]

0.00

0.0

1.4

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(40768795) Lymph node Pathology biopsy report

0.95

0.00

1.6

1.1

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

0.0

1.2

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

0.0

1.3

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

0.92

0.00

1.0

2.8

ug/l

12.5

527.1

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

0.0

8.0

—

(3026726) Creatinine [Moles/volume] in Specimen

0.00

0.0

2.5

—

340.0

—

(3024471) HLA-A [Type]

0.86

0.00

1.0

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

1.00

0.00

1.1

miu/ml

1663.4

1457.4

—

(3024932) HLA-DR beta [Type]

0.88

0.00

1.0

1.1

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

0.00

0.0

1.3

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3013466) aPTT in Blood by Coagulation assay

0.00

-0.00

0.0

1.3

—

37.6

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

7.6

—

0.5

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

-0.00

0.0

1.2

—

(3022670) pH of Venous cord blood

0.00

-0.00

0.0

1.2

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

-0.00

0.0

1.8

—

1.6

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.3

—

243.6

—

(3040661) Urea [Moles/volume] in Peritoneal dialysis fluid

0.00

-0.00

0.0

4.9

—

20.2

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

0.00

-0.00

0.0

1.2

—

65.4

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

0.00

-0.00

0.0

8.6

—

(3032333) Phosphate [Mass or Moles] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

(44806420)

0.00

-0.00

0.0

1.9

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.00

-0.00

0.0

1.3

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.4

—

(3000936) Kiwifruit IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

1.1

—

(3018081) Beta-2-Microglobulin [Mass/volume] in Urine

0.00

-0.00

0.0

1.8

—

20.2

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

-0.00

0.0

4.9

—

550.0

—

(36303722) Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.0

—

31.6

—

Mortality – FinRegistry

↥

Association

Association between endpoint F5_OPIOIDS and mortality.

Females

Parameter	HR [95% CI]	p-value
F5_OPIOIDS	4.677 [3.71, 5.89]	< 0.001
Birth year	0.997 [0.99, 1.0]	0.412

During the follow-up period (1.1.1998 — 31.12.2019), 741 out of 4868 females with F5_OPIOIDS died.

Males

Parameter	HR [95% CI]	p-value
F5_OPIOIDS	7.027 [5.93, 8.33]	< 0.001
Birth year	0.989 [0.98, 1.0]	0.013

During the follow-up period (1.1.1998 — 31.12.2019), 1696 out of 9514 males with F5_OPIOIDS died.

Mortality risk

Mortality risk for people of age

years, who have F5_OPIOIDS.

N-year risk	Females	Males
1	0.526%	1.405%
5	3.115%	8.123%
10	6.978%	19.772%
15	12.71%	34.813%
20	21.802%	52.633%

Relationships between endpoints

↥

Index endpoint: F5_OPIOIDS – Mental and behavioural disorders due to opioids

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Mental and behavioural disorders due to opioids

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints